Journal
JOURNAL OF VIRAL HEPATITIS
Volume 25, Issue 9, Pages 1038-1047Publisher
WILEY
DOI: 10.1111/jvh.12908
Keywords
chronic hepatitis B; HBV RNA; natural history
Funding
- National Natural Science Foundation of China [81373064, 81571981, 81670560]
- National Grand Program on Key Infectious Disease Control [2017ZX10302201-004-004]
- Specialized Project on Scientific Research within the health care industry of China [201302010]
- Chinese Foundation for Hepatitis Prevention and Control-TianQing Liver Disease Research Fund Subjects [TQGB20140064]
- Second Scientific Project of Yinzhou District of Ningbo [2014, 57]
Ask authors/readers for more resources
Virus-like particles encapsulating HBV-RNA represent a serum biomarker for assessing viral replication activity in clinical practice. However, baseline levels of serum HBV-RNA and their associations with viral replicative intermediates and liver disease in phases of chronic hepatitis B remain unknown. In this cross-sectional study, 102 patients were categorized into immune-tolerant (IT), HBeAg-positive immune active (HBeAg+IA), inactive carrier (IC) and HBeAg-negative immune active (HBeAg-IA) phases. HBV-RNA in serum samples and in 66 paired liver biopsies were quantified and correlated with serum ALT levels, histopathological scores and the levels of other viral replicative intermediates. Mean levels of serum HBV-RNA differed among phases, with the highest levels among IT (6.78 +/- 0.83 log(10) copies mL(-1)) patients, followed by HBeAg+IA (5.73 +/- 1.16 log(10) copies mL(-1)), HBeAg-IA (4.52 +/- 1.25 log(10) copies mL(-1)) and IC (2.96 +/- 0.40 log(10) copies mL(-1)) patients. Serum HBV-RNA levels correlated with HBV DNA in all phases, although correlations with other viral replicative intermediates weakened or disappeared when cases were stratified into phases. Distinct compositions of viral products were found among phases: the ratio of HBsAg to serum HBV-RNA was highest in IC patients, while the ratio of serum HBV-RNA to intrahepatic HBV-RNA and the ratio of intrahepatic HBV-DNA to intrahepatic HBV-RNA were significantly higher in IT patients. In conclusion, baseline levels of HBV-RNA and the composition of viral replicative intermediates differ significantly across the natural course of chronic HBV infection. These findings shed light on the nature of viral replication and pathogenesis of disease among different phases of chronic HBV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available